First-line systemic therapy for metastatic renal cell carcinoma: a systematic review and network meta-analysis

CJD Wallis, Z Klaassen, B Bhindi, YY Xiang… - European urology, 2018 - Elsevier
Context In the last decade, there has been a proliferation of treatment options for metastatic
renal cell carcinoma (mRCC). However, direct comparative data are lacking for most of …

First-line Systemic Therapy for Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-analysis [Figure presented]

CJD Wallis, Z Klaassen, B Bhindi… - European …, 2018 - mayoclinic.elsevierpure.com
Context: In the last decade, there has been a proliferation of treatment options for metastatic
renal cell carcinoma (mRCC). However, direct comparative data are lacking for most of …

[引用][C] First-line Systemic Therapy for Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-analysis

CJD Wallis, Z Klaassen, B Bhindi, XY Ye… - European Urology, 2018 - cir.nii.ac.jp
First-line Systemic Therapy for Metastatic Renal Cell Carcinoma: A Systematic Review and
Network Meta-analysis | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] …

First-line Systemic Therapy for Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-analysis.

CJD Wallis, Z Klaassen, B Bhindi, XY Ye… - European …, 2018 - europepmc.org
First-line Systemic Therapy for Metastatic Renal Cell Carcinoma: A Systematic Review and
Network Meta-analysis. - Abstract - Europe PMC Sign in | Create an account https://orcid.org …

First-line Systemic Therapy for Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-analysis

CJD Wallis, Z Klaassen, B Bhindi… - European …, 2018 - pubmed.ncbi.nlm.nih.gov
Context In the last decade, there has been a proliferation of treatment options for metastatic
renal cell carcinoma (mRCC). However, direct comparative data are lacking for most of …

First-line Systemic Therapy for Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-analysis [Figure presented]

CJD Wallis, Z Klaassen, B Bhindi… - European …, 2018 - augusta.elsevierpure.com
Context: In the last decade, there has been a proliferation of treatment options for metastatic
renal cell carcinoma (mRCC). However, direct comparative data are lacking for most of …